Craig Hallum Bullish on Dyadic International, Inc. (DYAI) With $5 Target

Core Insights - Dyadic International, Inc. (NASDAQ:DYAI) is recognized as a fundamentally strong penny stock with a 'Buy' rating and a price target of $5.00, indicating an upside potential of approximately 405.7% [1] - The company has shifted its focus from vaccine development to commercial applications, which is already yielding positive results, with potential monetary gains of $100 million over the next five years [2] Company Overview - Dyadic International, Inc. is a Florida-based biotechnology platform company that specializes in industrial enzymes and other proteins, aiming to revolutionize biotechnology since its incorporation in 1979 [4] Management Perspective - The management, led by President & COO Joseph P. Hazelton, believes the company has reached a commercial inflection point, enhancing its competitive position in the market [3]